Patents by Inventor Julie Mercure

Julie Mercure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
    Patent number: 6632835
    Abstract: Molecules demonstrating anti-proliferative effects against epithelial cancer cell lines and endothelial cells and methods of synthesis are disclosed. The molecules are intended for use in therapeutic preparations for the treatment of cancer through either anti-angiogenesis or other anti-cancer mechanisms. The compounds specified are 6H-dibenzo[b,d]pyran-6-one derivatives and have been shown to be antiproliferative against human endothelial cells.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: October 14, 2003
    Assignee: Nanodesign Inc.
    Inventors: Jonathan Martin Schmidt, Peter Redden, Julie Mercure, Shuguang Zhu, John Whelan, Natalie Lazarowych
  • Non-steroidal estrogen receptor ligands
    Patent number: 6599921
    Abstract: Novel non-steroidal estrogen receptor ligands and methods of synthesis are disclosed. The novel molecules are intended for use in therapeutic preparations for the treatment of estrogen receptor related disease states. The compounds specified are tetra-cyclic derivatives and have been shown to be antiproliferative against human estrogen-dependent cancer cells and to have good binding affinity for the estrogen receptor.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: July 29, 2003
    Assignee: NanoDesign, Inc.
    Inventors: Jonathan Martin Schmidt, Julie Mercure, Jeffry Lawrence Lowell, Stefan Kwiatkowski, Krzysztof Pupek, Shuguang Zhu, John Whelan, Natalie Lazarowych
  • Non-steroidal estrogen receptor ligands
    Publication number: 20020156077
    Abstract: Novel non-steroidal estrogen receptor ligands and methods of synthesis are disclosed. The novel molecules are intended for use in therapeutic preparations for the treatment of estrogen receptor related disease states. The compounds specified are tetra-cyclic derivatives and have been shown to be antiproliferative against human estrogen-dependent cancer cells and to have good binding affinity for the estrogen receptor.
    Type: Application
    Filed: August 21, 2001
    Publication date: October 24, 2002
    Inventors: Jonathan Martin Schmidt, Julie Mercure, Jeffry Lawrence Lowell, Stefan Kwiatkowski, Krzysztof Pupek, Shuguang Zhu, John Whelan, Natalie Lazarowych
  • 1,2-diphenyl-1-naphthyl ethene derivatives, analogs and use thereof
    Publication number: 20020147187
    Abstract: Molecules demonstrating anti-proliferative effects against epithelial cancer cell lines, human estrogen-dependent cancer cells and endothelial cells are disclosed. The molecules are intended for use in therapeutic preparations for the treatment of various cancers. The compounds specified are 1,2-diphenyl-1-naphthyl ethene derivatives.
    Type: Application
    Filed: August 21, 2001
    Publication date: October 10, 2002
    Inventors: Jonathan Martin Schmidt, Julie Mercure, Shuguang Zhu, John Whelan, Natalie Lazarowych
  • Dibenzo[c]chromen-6-one derivatives as anti-cancer agents
    Publication number: 20020115711
    Abstract: Molecules demonstrating anti-proliferative effects against epithelial cancer cell lines and endothelial cells and methods of synthesis are disclosed. The molecules are intended for use in therapeutic preparations for the treatment of cancer through either anti-angiogenesis or other anti-cancer mechanisms. The compounds specified are 6H-dibenzo[b,d]pyran-6-one derivatives and have been shown to be antiproliferative against human endothelial cells.
    Type: Application
    Filed: August 21, 2001
    Publication date: August 22, 2002
    Inventors: Johnathan Martin Schmidt, Peter Redden, Julie Mercure, Shuguang Zhu, John Whelan, Natalie Lazarowych